- Home
- PODD vs IP Comparison
PODD vs IP Comparison
Compare PODD & IP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PODD | IP |
|---|---|---|
| Founded | 2000 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1B | 20.6B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | PODD | IP |
|---|---|---|
| Price | $285.16 | $39.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 9 |
| Target Price | ★ $366.58 | $50.00 |
| AVG Volume (30 Days) | 653.6K | ★ 4.3M |
| Earning Date | 02-19-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 4.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.45 | N/A |
| Revenue | $2,521,800,000.00 | ★ $24,334,000,000.00 |
| Revenue This Year | $32.55 | $34.99 |
| Revenue Next Year | $20.50 | $0.99 |
| P/E Ratio | $82.37 | ★ N/A |
| Revenue Growth | 27.11 | ★ 47.35 |
| 52 Week Low | $230.05 | $35.56 |
| 52 Week High | $354.88 | $60.15 |
Technical Indicators
Market Signals| Indicator | PODD | IP |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 51.89 |
| Support Level | $285.02 | $38.03 |
| Resistance Level | $290.60 | $39.93 |
| Average True Range (ATR) | 5.58 | 0.63 |
| MACD | 0.15 | 0.20 |
| Stochastic Oscillator | 0.00 | 74.74 |
Price Performance
Historical ComparisonAbout PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About IP International Paper Company
International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one-third of the North American corrugated packaging market. The company also has a substantial presence in Europe following its acquisition of DS Smith. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.